"Fatty Acids, Omega-3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of unsaturated fatty acids occurring mainly in fish oils, with three double bonds at particular positions in the hydrocarbon chain.
| Descriptor ID |
D015525
|
| MeSH Number(s) |
D10.212.302.380.410 D10.251.355.337 D10.627.430.450
|
| Concept/Terms |
Fatty Acids, Omega-3- Fatty Acids, Omega-3
- n-3 Fatty Acids
- n 3 Fatty Acids
- n-3 Polyunsaturated Fatty Acid
- n 3 Polyunsaturated Fatty Acid
- n-3 PUFA
- PUFA, n-3
- n 3 PUFA
- Omega 3 Fatty Acids
- n3 PUFA
- PUFA, n3
- n3 Polyunsaturated Fatty Acid
- n3 Oils
- n-3 Oils
- n 3 Oils
- Omega-3 Fatty Acids
- n3 Fatty Acid
- Fatty Acid, n3
|
Below are MeSH descriptors whose meaning is more general than "Fatty Acids, Omega-3".
Below are MeSH descriptors whose meaning is more specific than "Fatty Acids, Omega-3".
This graph shows the total number of publications written about "Fatty Acids, Omega-3" by people in this website by year, and whether "Fatty Acids, Omega-3" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fatty Acids, Omega-3" by people in Profiles.
-
Plasma phospholipid n-3 and n-6 polyunsaturated fatty acids in relation to cardiometabolic markers and gestational diabetes: A longitudinal study within the prospective NICHD Fetal Growth Studies. PLoS Med. 2019 09; 16(9):e1002910.
-
Omega 3 polyunsaturated fatty acids and healthy ageing. BMJ. 2018 10 17; 363:k4263.
-
Effect of Combination Cholesterol-Lowering Therapy and Triglyceride-Lowering Therapy on Medical Costs in Patients With Type 2 Diabetes Mellitus. Am J Cardiol. 2017 Feb 01; 119(3):410-415.
-
Intake of fish and long-chain omega-3 polyunsaturated fatty acids and incidence of metabolic syndrome among American young adults: a 25-year follow-up study. Eur J Nutr. 2016 Jun; 55(4):1707-16.
-
Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms. Obstet Gynecol. 2015 Aug; 126(2):413-22.
-
Plasma nutrient biomarkers are associated with waist-to-height ratio in youth with type 1 diabetes. J Nutr. 2015 Mar; 145(3):579-86.
-
Cognitive impairment in ORIGIN: timing is everything. Lancet Diabetes Endocrinol. 2014 Jul; 2(7):531-2.
-
Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial. Menopause. 2014 Apr; 21(4):347-54.
-
Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network. Menopause. 2014 Jan; 21(1):45-58.
-
Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements. Am J Obstet Gynecol. 2014 Mar; 210(3):244.e1-11.